Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study)
Clinical Concordance Evaluation of the T-SPOT®.TB Assay Performance Using Positive Selection With the T-Cell SelectTM Kit and Density Gradient Cell Isolation Methods
Sponsor: Oxford Immunotec
Listed as NCT04141982, this observational or N/A phase trial focuses on Tuberculosis and remains completed. Sponsored by Oxford Immunotec, it has been updated 11 times since 2019, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2022 — Jul 2024 [monthly]
Completed
-
Apr 2021 — Apr 2022 [monthly]
Completed
Status: Suspended → Completed
-
Jan 2021 — Apr 2021 [monthly]
Suspended
▶ Show 6 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Suspended
-
May 2020 — Aug 2020 [monthly]
Suspended
Status: Recruiting → Suspended
-
Mar 2020 — May 2020 [monthly]
Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Oxford Immunotec
For direct contact, visit the study record on ClinicalTrials.gov .